Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Tinchon, C; Auner, HW; Beham-Schmid, C; Aberle, SW; Sill, H; Linkesch, W.
Symptomatic Epstein-Barr virus reactivation in a patient with acute myeloid leukaemia and treatment with the monoclonal anti-CD20 antibody rituximab.
EUR J HAEMATOL 2002 69: 50-53. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Beham-Schmid Christine
Linkesch Werner
Sill Heinz
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
In a patient with acute myeloid leukaemia, treated with several courses of chemotherapy including a fludarabine-containing regimen, severe symptoms due to Epstein-Barr virus reactivation occurred but could be successfully treated with the monoclonal anti-CD20 antibody rituximab. Depletion of viral host cells may be effective in treatment of symptoms due to Epstein-Barr virus reactivation.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Antibodies, Monoclonal - immunology
Antigens, CD20 - immunology
Antineoplastic Agents - therapeutic use
Herpesvirus 4, Human - isolation and purification
Humans - isolation and purification
Leukemia, Myeloid - drug therapy
Lymphocyte Depletion - drug therapy
Male - drug therapy
Virus Activation - drug therapy

Find related publications in this database (Keywords)
Epstein-Barr virus
rituximab
fludarabine
acute myeloid leukaemia
© Meduni Graz Impressum